Tag: FIRSTINCLASS
MedinCell – Successful recruitment for the phase 3 clinical study of F14 (mdc-CWM), a first-in-class localized treatment to relieve pain after knee replacement surgery – 08/30/2023 at 18 :54
MedinCell Announces Successful Recruitment for Phase 3 Clinical Study of F14 (mdc-CWM), a First-in-Class Localized Treatment for Post-Knee Replacement Pain Relief – Recruitment is complete after randomization of 151 patients…
NANOBIOTIX APPOINTS LEADING EXPERTS TO FORM ITS SCIENTIFIC ADVISORY BOARD FOR NBTXR3, ITS POTENTIAL FIRST-IN-CLASS RADIOENHANCER – 02/11/2022 at 21:30
This multidisciplinary Scientific Council includes twelve (12) American and European experts contributing their expertise to the development of the main product-candidate NBTXR3Paris, France ; Cambridge, Massachusetts (USA); November 2, 2022…